These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20532595)

  • 21. Diversity Oriented Synthesis of Novel Xanthones Reveal Potent Doxorubicin-Inspired Analogs.
    Meringdal JW; Bade L; Bendas G; Menche D
    ChemMedChem; 2024 May; 19(9):e202400055. PubMed ID: 38351738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological activity, quantitative structure-activity relationship analysis, and molecular docking of xanthone derivatives as anticancer drugs.
    Miladiyah I; Jumina J; Haryana SM; Mustofa M
    Drug Des Devel Ther; 2018; 12():149-158. PubMed ID: 29391779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Progress in research of the structural optimization of natural product-like Garcinia caged xanthones].
    Wang YY; Zhang XJ; Yang YR; Sun HP; You QD
    Yao Xue Xue Bao; 2014 Mar; 49(3):293-302. PubMed ID: 24961098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xanthone Conjugated Amino Acids as Potential Anticancer and DNA Binding Agents: Molecular Docking, Cytotoxicity and SAR Studies.
    Rakesh KP; Darshini N; Manukumar HM; Vivek HK; Eissa MYH; Prasanna DS; Mallesha N
    Anticancer Agents Med Chem; 2018; 18(15):2169-2177. PubMed ID: 30179146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
    Jun KY; Lee EY; Jung MJ; Lee OH; Lee ES; Park Choo HY; Na Y; Kwon Y
    Eur J Med Chem; 2011 Jun; 46(6):1964-71. PubMed ID: 21419530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent cancer drug development with xanthone structures.
    Na Y
    J Pharm Pharmacol; 2009 Jun; 61(6):707-12. PubMed ID: 19505360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, structure-activity relationship and in vitro pharmacodynamics of A-ring modified caged xanthones in a preclinical model of inflammatory breast cancer.
    Chantarasriwong O; Milcarek AT; Morales TH; Settle AL; Rezende CO; Althufairi BD; Theodoraki MA; Alpaugh ML; Theodorakis EA
    Eur J Med Chem; 2019 Apr; 168():405-413. PubMed ID: 30831408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chiral derivatives of xanthones and benzophenones: Synthesis, enantioseparation, molecular docking, and tumor cell growth inhibition studies.
    Phyo YZ; Teixeira J; Gonçalves R; Palmeira A; Tiritan ME; Bousbaa H; Pinto MMM; Fernandes C; Kijjoa A
    Chirality; 2021 Apr; 33(4):153-166. PubMed ID: 33448056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xanthone derivatives as phosphoglycerate mutase 1 inhibitors: Design, synthesis, and biological evaluation.
    Wang P; Jiang L; Cao Y; Zhang X; Chen B; Zhang S; Huang K; Ye D; Zhou L
    Bioorg Med Chem; 2018 May; 26(8):1961-1970. PubMed ID: 29530347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of novel 1-hydroxyl-3-aminoalkoxy xanthone derivatives as potent anticancer agents.
    Yang ZM; Huang J; Qin JK; Dai ZK; Lan WL; Su GF; Tang H; Yang F
    Eur J Med Chem; 2014 Oct; 85():487-97. PubMed ID: 25113877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidimensional optimization of promising antitumor xanthone derivatives.
    Azevedo CM; Afonso CM; Sousa D; Lima RT; Vasconcelos MH; Pedro M; Barbosa J; Corrêa AG; Reis S; Pinto MM
    Bioorg Med Chem; 2013 Jun; 21(11):2941-59. PubMed ID: 23623253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromoalkoxyxanthones as promising antitumor agents: synthesis, crystal structure and effect on human tumor cell lines.
    Sousa E; Paiva A; Nazareth N; Gales L; Damas AM; Nascimento MS; Pinto M
    Eur J Med Chem; 2009 Sep; 44(9):3830-5. PubMed ID: 19428155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Click Chemistry' Synthesis of Novel Natural Product-Like Caged Xanthones Bearing a 1,2,3-Triazole Moiety with Improved Druglike Properties as Orally Active Antitumor Agents.
    Li X; Wu Y; Wang Y; You Q; Zhang X
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29077076
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis, SAR and biological evaluation of natural and non-natural hydroxylated and prenylated xanthones as antitumor agents.
    Zhang X; Li X; Ye S; Zhang Y; Tao L; Gao Y; Gong D; Xi M; Meng H; Zhang M; Gao W; Xu X; Guo Q; You Q
    Med Chem; 2012 Nov; 8(6):1012-25. PubMed ID: 22779801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7.
    Castanheiro RA; Pinto MM; Silva AM; Cravo SM; Gales L; Damas AM; Nazareth N; Nascimento MS; Eaton G
    Bioorg Med Chem; 2007 Sep; 15(18):6080-8. PubMed ID: 17614292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and anticancer potential of novel xanthone derivatives with 3,6-substituted chains.
    Liu C; Zhang M; Zhang Z; Zhang SB; Yang S; Zhang A; Yin L; Swarts S; Vidyasagar S; Zhang L; Okunieff P
    Bioorg Med Chem; 2016 Sep; 24(18):4263-4271. PubMed ID: 27448774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, cytotoxicity and DNA binding of oxoazabenzo[de]anthracenes derivatives in colon cancer Caco-2 cells.
    Di Salvo A; Dugois P; Tandeo D; Peltekian M; Kong Thoo Lin P
    Eur J Med Chem; 2013 Nov; 69():754-61. PubMed ID: 24099994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New chiral derivatives of xanthones: synthesis and investigation of enantioselectivity as inhibitors of growth of human tumor cell lines.
    Fernandes C; Masawang K; Tiritan ME; Sousa E; de Lima V; Afonso C; Bousbaa H; Sudprasert W; Pedro M; Pinto MM
    Bioorg Med Chem; 2014 Feb; 22(3):1049-62. PubMed ID: 24411197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and biological evaluation of 1,3,6,7-tetrahydroxyxanthone derivatives as phosphoglycerate mutase 1 inhibitors.
    Jiang K; Gao B; Yu J; Jiang L; Niu A; Jia Y; Meng T; Zhou L; Wang J
    Bioorg Med Chem Lett; 2021 Mar; 36():127820. PubMed ID: 33513389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and cytotoxic activity of benzo[a]pyrano[3,2-h] and [2,3-i]xanthone analogues of psorospermine, acronycine, and benzo[a]acronycine.
    Sittisombut C; Boutefnouchet S; Trinh Van-Dufat H; Tian W; Michel S; Koch M; Tillequin F; Pfeiffer B; Pierré A
    Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1113-8. PubMed ID: 16880654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.